Regional/Distant Stage Prostate Cancer Incidence by Year, White Individuals, New York City, 1976-2020
Source: New York State Cancer Registry
| Year of Diagnosis | Cases | Rate per 100,000 Males | 95% CI |
|---|---|---|---|
| 1976 | 548 | 23.5 | 21.4-25.6 |
| 1977 | 527 | 22.4 | 20.4-24.5 |
| 1978 | 545 | 23.4 | 21.4-25.5 |
| 1979 | 573 | 25.5 | 23.4-27.8 |
| 1980 | 568 | 25.2 | 23.1-27.4 |
| 1981 | 581 | 26.2 | 24.0-28.5 |
| 1982 | 614 | 27.6 | 25.4-29.9 |
| 1983 | 576 | 26.0 | 23.9-28.3 |
| 1984 | 598 | 26.9 | 24.8-29.3 |
| 1985 | 581 | 26.3 | 24.1-28.6 |
| 1986 | 568 | 26.2 | 24.0-28.5 |
| 1987 | 554 | 25.2 | 23.2-27.5 |
| 1988 | 521 | 24.6 | 22.5-26.9 |
| 1989 | 539 | 25.7 | 23.6-28.0 |
| 1990 | 585 | 28.4 | 26.1-30.8 |
| 1991 | 639 | 30.7 | 28.4-33.3 |
| 1992 | 598 | 28.8 | 26.5-31.2 |
| 1993 | 560 | 27.4 | 25.1-29.7 |
| 1994 | 535 | 26.0 | 23.8-28.3 |
| 1995 | 462 | 22.7 | 20.7-24.9 |
| 1996 | 422 | 20.8 | 18.8-22.8 |
| 1997 | 411 | 20.4 | 18.5-22.5 |
| 1998 | 341 | 16.9 | 15.1-18.8 |
| 1999 | 362 | 17.9 | 16.1-19.8 |
| 2000 | 340 | 16.5 | 14.8-18.4 |
| 2001 | 330 | 15.8 | 14.1-17.6 |
| 2002 | 334 | 16.0 | 14.4-17.9 |
| 2003 | 309 | 14.7 | 13.1-16.4 |
| 2004 | 340 | 15.9 | 14.3-17.7 |
| 2005 | 378 | 17.6 | 15.8-19.5 |
| 2006 | 412 | 19.2 | 17.4-21.2 |
| 2007 | 436 | 20.1 | 18.3-22.1 |
| 2008 | 404 | 18.5 | 16.7-20.4 |
| 2009 | 461 | 20.6 | 18.8-22.6 |
| 2010 | 460 | 20.4 | 18.6-22.4 |
| 2011 | 476 | 20.9 | 19.0-22.9 |
| 2012 | 430 | 18.4 | 16.7-20.3 |
| 2013 | 481 | 20.4 | 18.6-22.4 |
| 2014 | 483 | 20.1 | 18.4-22.1 |
| 2015 | 502 | 20.7 | 18.9-22.6 |
| 2016 | 550 | 22.4 | 20.5-24.4 |
| 2017 | 580 | 23.6 | 21.7-25.6 |
| 2018 | 595 | 24.0 | 22.1-26.1 |
| 2019 | 596 | 23.6 | 21.8-25.6 |
| 2020 | 553 | 21.9 | 20.1-23.8 |
Notes
- Incidence data are provisional, November 2022.
- Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
- Rates based on fewer than 20 cases per year are unstable and should be used with caution.
- Regional/distant stage indicates disease has spreaded beyond the limits of the organ of origin at diagnosis.
